Arterra Bioscience SpaMIL: ARBS

ARBS: Strong profit growth and R&D advances support a positive outlook and dividend proposal

· Issued by Arterra Bioscience Spa

Production value and net profit grew strongly year-over-year, driven by a surge in cosmetic raw material sales and robust R&D activity. Financial position remains solid, with optimism for continued growth in 2025 and a proposed dividend of €0.13 per share.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Earlier from Arterra Bioscience Spa

All Arterra Bioscience Spa news releases